Primary liver cancer is one of the common malignant tumors in China, and in recent years, the incidence of primary liver cancer in China is slowly increasing. For primary liver cancer patients and their family members, they must clarify the following primary liver cancer treatment misconceptions. One of the treatment misconceptions of primary liver cancer: surgery is the cure Some patients and family members lack medical common sense and do not understand the metastatic and invasive nature of malignant tumors, and tumor cells can metastasize to the whole body through lymph and blood. After surgery, they are blindly optimistic and do not pay attention to the follow-up treatment, which eventually affects the survival quality of patients, and some patients are afraid of the toxic side effects of radiotherapy and chemotherapy and give up the follow-up treatment. These are all mistakes. After surgery, primary liver cancer does not mean that it is cured, and there is still a possibility of recurrence, and if the surgery is incomplete, there is even a possibility of metastasis and spread. Therefore, patients should establish the concept that the treatment of liver cancer is a long-term and systematic process. After primary liver cancer surgery, appropriate adjuvant treatments, such as radiotherapy and Chinese medicine, should be selected according to specific conditions. Among them, Chinese medicine treatment has gradually become an important treatment means after primary liver cancer surgery, which can not only prevent recurrence, but also improve the body’s resistance to disease and accelerate the recovery of body functions. Misconception of primary liver cancer treatment No. 2: No more review after discharge Regular review and emphasis on follow-up treatment are especially important for primary liver cancer patients whose symptoms have improved. After the surgery and radiotherapy, some patients give up the follow-up treatment after the symptoms are relieved or the mass disappears, and as a result, the tumor recurs or metastases occur, so that the treatment is abandoned. Regular review is a very important part of the treatment of primary liver cancer to understand the transformation of the disease so that further follow-up treatment can be carried out in case of improvement or recurrence. With the progress of early diagnosis and treatment methods and the development of anti-tumor drugs, the cure rate of primary liver cancer patients is getting higher and higher, but there are still some patients who believe in the so-called ancestral cancer treatment recipes and prescriptions, which have complicated ingredients and few real anti-tumor ingredients and are not effective in killing tumor cells. Due to the patients’ eagerness to seek treatment, they blindly believe in secret prescriptions, partial prescriptions and so-called cancer treatment experts, wasting their money and losing the best treatment time. Therefore, patients must choose regular medical institutions for treatment and choose regular primary liver cancer drugs approved by the state. The fourth misconception of primary liver cancer treatment: relying on nutritional food Some patients are convinced of certain health food that “cure all cancers” and take it for a long time, thus giving up regular treatment, which is a very wrong concept. Nutritional products and health care products are not drugs and cannot replace regular drugs in cancer treatment. Moreover, the exaggerated propaganda of curing all cancers is not in line with scientific rules. Patients must adhere to the regular long-term treatment plan and choose the appropriate medicine in a targeted way. Only by cooperating with the treatment plan of doctors can the best primary liver cancer treatment results be obtained. In general, the treatment of primary liver cancer is a long-term and comprehensive process. Patients and their family members should clarify the misunderstandings of primary liver cancer treatment, choose regular treatment institutions and receive correct treatment means in order to fundamentally cure primary liver cancer. When primary liver cancer is accompanied with ascites, jaundice and distant metastasis, it is called advanced primary liver cancer. The treatment of advanced primary liver cancer is more difficult and the clinical treatment effect is not ideal, nowadays, most of the treatment methods are combined with Chinese and Western medicine. In general, the treatment principles of advanced primary liver cancer include the following aspects: for primary liver cancer with ascites, it can be treated with Chinese medicine or western diuretics first, and after the ascites subsides, it can still be treated according to the above method according to the situation of tumor in liver. If the ascites is hematogenous, it is not easy to subside; if there is cancer thrombus in portal vein or hepatic vein, diuretics of Chinese and western medicines are not effective. If primary hepatocellular carcinoma nodules rupture and bleed, hemostatic treatment should be given, and abdominal compression bandage should be applied at the same time. For primary hepatocellular carcinoma with jaundice, if it is obstructive jaundice caused by mass compression in the hilar area, local radiation therapy, local intratumoral injection, interventional therapy, internal stenting or external drainage can be used; if it is non-jaundice, Chinese medicine treatment and liver preservation therapy can be given. For primary liver cancer with lung metastasis, if the primary foci of liver cancer have been controlled and there is only a single lung metastasis, resection or local radiotherapy can be considered. For multiple metastases or diffuse metastases in both lungs, radiotherapy (whole lung irradiation), chemotherapy or biotherapy can be considered. If the primary foci of liver cancer are not treated or not controlled by treatment, and the metastases are single or more limited, radiotherapy can also be considered. If the metastasis is diffuse in the whole lung, biological therapy, chemotherapy or Chinese medicine can be used. For advanced primary liver cancer bone metastases, if the metastases are single or several, radiotherapy can be used. If the bone metastasis is extensive, chemotherapy, biological therapy or radionuclide therapy can be given, as well as treatment with bone phosphine and Akodan. For those with cancer thrombus in portal vein, hepatic vein and inferior vena cava, chemotherapy with hepatic artery infusion can be tried, and in general, hepatic artery embolization is not used, and biological therapy or Chinese medicine can be used.